Delivery Order #15B50526F00000191

Delivery Order for Lenalidomide Capsules under VA Pharmaceuticals Contract

This contract represents a delivery order issued under an existing multiple-award Federal Supply Schedule contract held by EXELAN Pharmaceuticals Inc., a U.S.-incorporated foreign-owned pharmaceutical company specializing in delivering essential drug products to federal agencies. The delivery order procures Lenalidomide 10mg capsules, a medication used in hematology and oncology treatments, for the Department of Veterans Affairs, reflecting the agency's ongoing commitment to providing critical pharmaceuticals to veterans. The scope includes the supply of this specific drug for a three-month period, ensuring continuity of care in veteran healthcare services. This award follows from a highly competitive, multi-year federal contract enabling steady access to a range of pharmaceuticals, and represents a supplemental acquisition within that framework. The order was recently awarded with a defined performance period in mid-2026, reinforcing EXELAN's role as a key supplier in the federal pharmaceutical space under the existing contract vehicle. There is no indication of sole-source procurement for this delivery order, consistent with the broad competitive nature of the parent contract.

Description

EXELAN, LENALIDOMIDE 10MG CAP, JUL-SEP FY26|!#^$351.76 X 21 $7,386.96 X 3 MONTHS $22,160.88

View original record